{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/686e5d928d3d6839f4faaadc/687616d701becb6b317f9319?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Our Experience is Your Strength – High value, low loss: Developing a successful GT fill&finish strategy – Ep2","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/686e5d928d3d6839f4faaadc/1752569510368-ac9c0241-2e05-4bfe-9570-0f9449b813dc.jpeg?height=200","description":"<p>In this episode of <em>Our Experience is Your Strength</em>, host Steve Jacobs speaks with Xufeng Sun, Vice President of Manufacturing Science &amp; Technology at Sharp Sterile, about the critical, and often underestimated, challenges of gene therapy fill &amp; finish. With limited drug substance, high manufacturing costs, and tight quality constraints, every drop counts. Sun offers deep insight into the technical, logistical, and strategic considerations required to ensure success.&nbsp;The conversation covers key planning stages, from understanding clinical demand and testing requirements to visualising the entire manufacturing process, including thawing, filtration, and final inspection steps.</p>","author_name":"GlobalData Marketing Solutions"}